MedlineFRA:L10 +5.16%14 Market Cap is €28,893 Mil as of Jun. 28, 2026. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Medline ranks better than 98.62% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medline's share price for the quarter that ended in Mar. 2026 was €36.6. Medline's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 846 Mil. Therefore, Medline's market cap for the quarter that ended in Mar. 2026 was €30,964 Mil.
Medline's quarterly market cap
increased
from Sep. 2025 (€0 Mil) to Dec. 2025 (€28,542 Mil) and
increased
from Dec. 2025 (€28,542 Mil) to Mar. 2026 (€30,964 Mil).
Medline's annual market cap
stayed the same
from Dec. 2023 (€0 Mil) to Dec. 2024 (€0 Mil) but then
increased
from Dec. 2024 (€0 Mil) to Dec. 2025 (€28,542 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medline's Enterprise Value for Today is €45,026 Mil.
Medline (FRA:L10) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medline Market Cap Related Terms
Medline Market Cap Historical Data
* Premium members only.
The historical data trend for Medline's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Medline's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medline Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medline's Market Cap distribution charts can be found below:
* The bar in red indicates where Medline's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medline's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medline (FRA:L10) has a Market Cap of €28,893 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medline and its competitors. According to the industry distribution chart, Medline ranks #12 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 1.4%.
Is Medline's Market Cap too high?
Medline's current Market Cap is €28,893 Mil. Based on the distribution chart, Medline ranks #12 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Market Cap compare to RMD and WST?
According to the Medical Devices & Instruments industry distribution chart, Medline ranks #12 out of 868 companies for Market Cap. This places Medline in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 118.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.39, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medline and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medline's current Market Cap is €28,893 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Market Cap of €28,893 Mil. The current Market Cap is €28,893 Mil. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medline (FRA:L10), the current Market Cap is €28,893 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score
Get the complete analysis for FRA:L10
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L10 has been successfully added to your 
